Yoshiyuki Hashimoto

Mutagenicity of carcinogenic azo dyes and their derivatives

Takie Yahagi, Masakuni Degawa, Yuko Seino et al. · Cancer Letters · 1975 · 395 citations

Derivatives, Medicine, Toxicology +6

Physical and functional interactions between the transcription factor PU.1 and the coactivator CBP

Hitomi Yamamoto, Fumiko Kihara‐Negishi, Toshiyuki Yamada et al. · Oncogene · 1999 · 109 citations

Transcriptional Regulation, Transcription Factor Pu.1, Signal Transduction +13

Antitumor effect of Bifidobacterium infantis in mice.

Yoshinori Kohwi, Kazuhiro Imai, Zenzo Tamura et al. · PubMed · 1978 · 102 citations

Antibiotics, Antibacterial Agent, Antimicrobial Therapy +7

Oncogenicity of L-type amino-acid transporter 1 (LAT1) revealed by targeted gene disruption in chicken DT40 cells: LAT1 is a promising molecular target for human cancer therapy

M. Ohkawa, Yoshiya Ohno, Kazue Masuko et al. · Biochemical and Biophysical Research Communications · 2011 · 97 citations

Targeted Gene Disruption, Human Cancer Therapy, Oncogenic Agent +9

Clinical application of monoclonal antibody-drug conjugates for immunotargeting chemotherapy of colorectal carcinoma

Toshio Takahashi, Toshiharu Yamaguchi, Kazuya Kitamura et al. · Cancer · 1988 · 91 citations · Full text